SCHEMBL16014170

SCHEMBL16014170

CCOc1ccc(Nc2ncncc2[N+](=O)[O-])cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.57
ALDH1A1 P00352 3/20 0.57
HTT P42858 2/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
POLB P06746 3/20 0.49
GAA P10253 1/20 0.47
TTBK1 Q5TCY1 1/20 0.47
TTBK2 Q6IQ55 1/20 0.47
MAPK1 P28482 3/20 0.47
AURKA O14965 1/20 0.47
GSK3A P49840 1/20 0.47
GSK3B P49841 1/20 0.47
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
SYK P43405 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27618363 0.81 GSK3B (0.54) MAPTALDH1A1HTTL3MBTL1MEN1
SCHEMBL654394 0.81 GSK3B (0.69) MAPTALDH1A1HTTL3MBTL1MEN1
SCHEMBL1699158 0.81 MAPT (0.48) MAPTALDH1A1HTTMEN1KMT2A
SCHEMBL16014941 0.80 PIN1 (0.67) MAPTALDH1A1HTTL3MBTL1MEN1
SCHEMBL15201502 0.77 TDP1 (0.61) MAPTALDH1A1HTTL3MBTL1MEN1
SCHEMBL5413779 0.77 GSK3B (0.60) MAPTALDH1A1HTTL3MBTL1MEN1
SCHEMBL720482 0.76 NPC1 (0.56) MAPTALDH1A1HTTL3MBTL1MEN1
SCHEMBL11856114 0.73 PGK1 (0.47) MAPTL3MBTL1NPC1RAB9APOLB
SCHEMBL11348624 0.73 PTGS2 (0.67) MAPTALDH1A1HTTL3MBTL1MEN1
SCHEMBL5838060 0.73 MAPK1 (0.62) MAPTALDH1A1HTTL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964648-A1 9-(ARYL OR HETEROARYL)-2-(PYRAZOLYL, PYRROLIDINYL OR CYCLOPENTYL)AMINOPURINE DERIVATIVES AS ANTICANCER AGENTS Merck Patent GmbH (DE) 2016-01-13 EP disclosed
WO-2014135245-A1 9-(ARYL OR HETEROARYL)-2-(PYRAZOLYL, PYRROLIDINYL OR CYCLOPENTYL)AMINOPURINE DERIVATIVES AS ANTICANCER AGENTS MERCK PATENT GMBH (DE) 2014-09-12 WO disclosed